Free Trial

Canaccord Genuity Group Reaffirms "Hold" Rating for DocGo (NASDAQ:DCGO)

DocGo logo with Medical background

Canaccord Genuity Group reaffirmed their hold rating on shares of DocGo (NASDAQ:DCGO - Free Report) in a report released on Monday, Marketbeat Ratings reports. They currently have a $1.45 price target on the stock, down from their prior price target of $5.00.

A number of other equities research analysts have also recently commented on DCGO. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and decreased their price target for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Stifel Nicolaus reduced their price objective on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Needham & Company LLC reduced their price objective on DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Finally, BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $3.56.

View Our Latest Report on DocGo

DocGo Price Performance

Shares of DCGO traded up $0.07 during mid-day trading on Monday, reaching $1.47. 1,655,608 shares of the company's stock traded hands, compared to its average volume of 790,893. The stock has a market cap of $149.92 million, a P/E ratio of 5.25, a P/E/G ratio of 14.16 and a beta of 1.14. The stock's 50-day moving average is $2.37 and its two-hundred day moving average is $3.61. DocGo has a 12 month low of $1.35 and a 12 month high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). The business had revenue of $96.03 million for the quarter, compared to the consensus estimate of $104.25 million. DocGo had a net margin of 4.35% and a return on equity of 8.90%. Research analysts predict that DocGo will post 0.25 earnings per share for the current year.

Institutional Investors Weigh In On DocGo

Several large investors have recently bought and sold shares of DCGO. Vanguard Group Inc. boosted its position in shares of DocGo by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company's stock worth $21,261,000 after acquiring an additional 14,454 shares in the last quarter. WCM Investment Management LLC boosted its position in shares of DocGo by 64.2% during the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock worth $18,637,000 after acquiring an additional 1,687,100 shares in the last quarter. Punch & Associates Investment Management Inc. boosted its position in shares of DocGo by 17.4% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock worth $5,812,000 after acquiring an additional 325,760 shares in the last quarter. Jefferies Financial Group Inc. boosted its position in shares of DocGo by 6,874.1% during the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock worth $5,358,000 after acquiring an additional 2,000,356 shares in the last quarter. Finally, P.A.W. Capital Corp boosted its position in shares of DocGo by 25.0% during the 1st quarter. P.A.W. Capital Corp now owns 2,000,000 shares of the company's stock worth $5,280,000 after acquiring an additional 400,000 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Recommended Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines